Alice Jiang supports clients by utilizing her background in market research and public health.
Before joining Avalere, Alice interned with the rare disease market access team at Pfizer, where she helped conceptualize a case study on alternative pathways for sickle-cell disease medication in low- and middle-income countries and Sub-Saharan Africa. She also supported research on clinical and marketing strategies for therapies against transthyretin amyloid cardiomyopathy.
Alice holds a BA in public health and sociology from New York University and an MPH in chronic disease epidemiology from Yale School of Public Health.
Authored Content
A detailed Avalere report offers insights into state-specific statutes guiding commercial payer coverage for off-label use of oncology drugs/biologics.
The 2025 edition of the annual report provides insights into state statutes on point-of-service substitution of biosimilar products and is available